. Covaxin belongs to a league of vaccines that has been approved without establishing its efficacy. ..find an error and explain?
Answers
Answer:
The error is "Covaxin belongs to a league of vaccines that have been approved without establishing its efficacy"
Explanation:
It is talking about a group of things.
Mark my answer as the brainliest.
Answer:
all began when the regulator said the vaccine had been approved for "restricted use in emergency situations in public interest as an abundant precaution, in clinical trial mode, especially in the context of infection by mutant strains".
Experts wondered how a vaccine was cleared for emergency use by millions of vulnerable people when its trials were still underway.
Both the manufacturer and drug regulator say Covaxin is "safe and provides a robust immune response".
But the All India Drug Action Network said it was "baffled to understand the scientific logic" to approve "an incompletely studied vaccine". It said that there were "intense concerns arising from the absence of the efficacy data".
Bharat Biotech has defended the approval, saying Indian clinical trial laws allowed "accelerated" authorisation for use of drugs after the second phase of trials for "unmet medical needs of serious and life-threatening diseases in the country". It has promised to provide efficacy data for the vaccine by February.